［1］Kim HI，Schultz CR，Buras AL，et al.Ornithine decarboxylase as a therapeutic target for endometrial cancer［J］.PLoS One，2017，12(12)：e0189044.
[2]Lai Y，Sun C.Association of abnormal glucose metabolism and insulin resistance in patients with atypical and typical endometrial cancer［J］.Oncol Lett，2018，15(2)：2173-2178.
[3]Kulda V，Svaton M，Mukensnabl P，et al.Predictive relevance of miR-34a，miR-224 and miR-342 in patients with advanced squamous cell carcinoma of the lung undergoing palliative chemotherapy［J］.Oncol Lett，2018，15(1)：592-599.
[4]Wen F，An C，Wu X，et al.MiR-34a regulates mitochondrial content and fat ectopic deposition induced by resistin through the AMPK/PPAR alpha pathway in HepG2 cells［J］.Int J Biochem Cell Biol，2018，94：133-145.
[5]Seagle BL，Alexander AL，Lantsman T，et al.Prognosis and treatment of positive peritoneal cytology in early endometrial cancer：Matched cohort analyses from the national cancer database［J］.Am J Obstet Gynecol，2018，218(3)：329.e1- 329.e15.
[6]Li ZH，Weng X，Xiong QY，et al.miR-34a expression in human breast cancer is associated with drug resistance［J］.Oncotarget，2017，8(63)：106270-106282.
[7]Tang Kai，Cui Yulan.miRNA research progress in the pathogenesis of endometrial cancer［J］.Modern Oncology，2016，24(5)：831-834.［唐开，崔玉兰.miRNA在子宫内膜癌发病机制中的研究进展［J］.现代肿瘤医学，2016，24(5)：831-834.］
[8]He R，Liu P，Xie X，et al.circGFRA1 and GFRA1 act as ceRNAs in triple negative breast cancer by regulating miR-34a［J］.J Exp Clin Cancer Res，2017，36(1)：145.
[9]Chao J，Guo Y，Li P，et al.Role of kallistatin treatment in aging and cancer by modulating miR-34a and miR-21 expression［J］.Oxid Med Cell Longev，2017，2017：5025610.
[10]Fialkova V，Vidomanova E，Balharek T，et al.DNA methylation as mechanism of apoptotic resistance development in endometrial cancer patients［J］.Gen Physiol Biophys，2017，36(5)：521-529.
[11]Jia D，Niu Y，Li D，et al.lncRNA C2dat1 promotes cell proliferation，migration，and invasion by targeting miR-34a-5p in osteosarcoma cells［J］.Oncol Res，2018,26(5):753-764.
[12]Pu Y，Zhao F，Wang H，et al.MiR-34a-5p promotes multi-chemoresistance of osteosarcoma through down-regulation of the DLL1 gene［J］.Sci Rep，2017，7：44218.
[13]Shi W，Wang X，Ruan L，et al.MiR-200a promotes epithelial-mesenchymal transition of endometrial cancer cells by negatively regulating FOXA2 expression［J］.Pharmazie，2017，72(11)：694-699.
[14]Zhang S，Liu J，Xu K，et al.Notch signaling via regulation of RB and p-AKT but not PIK3CG contributes to MIA PaCa-2 cell growth and migration to affect pancreatic carcinogenesis［J］.Oncol Lett，2018，15(2)：2105-2110.
[15]Sun Z，Zhou C，Liu F，et al.Inhibition of breast cancer cell survival by xanthohumol via modulation of the Notch signaling pathway in vivo and in vitro［J］.Oncol Lett，2018，15(1)：908-916.
[16]Steinbuck MP，Arakcheeva K，Winandy S，et al.Novel TCR-mediated mechanisms of notch activation and signaling［J］.J Immunol，2018，200(3)：997-1007.
[17]Erkenbrack EM.Notch-mediated lateral inhibition is an evolutionarily conserved mechanism patterning the ectoderm in echinoids［J］.Dev Genes Evol，2018，228(1)：1-11.